MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 10, 2007; DOI: 10.1124/mol.107.034868


0026-895X/07/7203-665-673$20.00
Mol Pharmacol 72:665-673, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.034868v1
72/3/665    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MolPharm
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pannaccione, A.
Right arrow Articles by Annunziato, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pannaccione, A.
Right arrow Articles by Annunziato, L.

Up-Regulation and Increased Activity of KV3.4 Channels and Their Accessory Subunit MinK-Related Peptide 2 Induced by Amyloid Peptide Are Involved in Apoptotic Neuronal Death

A. Pannaccione, F. Boscia, A. Scorziello, A. Adornetto, P. Castaldo, R. Sirabella, M. Taglialatela, G. F. Di Renzo, and L. Annunziato

Division of Pharmacology, Department of Neuroscience, School of Medicine, Federico II University of Naples, Naples, Italy

The aim of the present study was to investigate whether KV3.4 channel subunits are involved in neuronal death induced by neurotoxic beta-amyloid peptides (Abeta). In particular, to test this hypothesis, three main questions were addressed: 1) whether the Abeta peptide can up-regulate both the transcription/translation and activity of KV3.4 channel subunit and its accessory subunit, MinK-related peptide 2 (MIRP2); 2) whether the increase in KV3.4 expression and activity can be mediated by the nuclear factor-{kappa}B (NF-{kappa}B) family of transcriptional factors; and 3) whether the specific inhibition of KV3.4 channel subunit reverts the Abeta peptide-induced neurodegeneration in hippocampal neurons and nerve growth factor (NGF)-differentiated PC-12 cells. We found that Abeta1–42 treatment induced an increase in KV3.4 and MIRP2 transcripts and proteins, detected by reverse transcription-polymerase chain reaction and Western blot analysis, respectively, in NGF-differentiated PC-12 cells and hippocampal neurons. Patch-clamp experiments performed in whole-cell configuration revealed that the Abeta peptide caused an increase in IA current amplitude carried by KV3.4 channel subunits, as revealed by their specific blockade with blood depressing substance-I (BDS-I) in both hippocampal neurons and NGF-differentiated PC-12 cells. The inhibition of NF-{kappa}B nuclear translocation with the cell membrane-permeable peptide SN-50 prevented the increase in KV3.4 protein and transcript expression. In addition, the SN-50 peptide was able to block Abeta1–42-induced increase in KV3.4 K+ currents and to prevent cell death caused by Abeta1–42 exposure. Finally, BDS-I produced a similar neuroprotective effect by inhibiting the increase in KV3.4 expression. As a whole, our data indicate that KV3.4 channels could be a novel target for Alzheimer's disease pharmacological therapy.


Received February 7, 2007; accepted May 10, 2007

Address correspondence to: Dr. Lucio Annunziato, Division of Pharmacology, Department of Neuroscience, School of Medicine, University of Naples Federico II, Building 19, Via Pansini 5, 80131 Naples, Italy. E-mail: lannunzi{at}unina.it


Related articles in MolPharm:

The MiRP2-Kv3.4 Potassium Channel: Muscling In on Alzheimer's Disease
Eun Choi and Geoffrey W. Abbott
MolPharm 2007 72: 499-501. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
E. Choi and G. W. Abbott
The MiRP2-Kv3.4 Potassium Channel: Muscling In on Alzheimer's Disease
Mol. Pharmacol., September 1, 2007; 72(3): 499 - 501.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics